Weiss Multi-Strategy Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200,000
Closed -$7.87M 783
2023
Q2
$7.87M Buy
+200,000
New +$7.06M 0.16% 190
2015
Q3
Sell
-10,000
Closed -$521K 516
2015
Q2
$521K Hold
10,000
0.02% 378
2015
Q1
$465K Buy
+10,000
New +$519K 0.02% 375

Weiss Multi-Strategy Advisers's ISEE Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 42,176 shares — an estimated $1.66M sold.

Weiss Multi-Strategy Advisers first reported a position in ISEE in Q2 2016 and held it in 3 quarters. The position peaked at $1.66M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 42,176 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.66M.
  • Weiss Multi-Strategy Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's IVERIC bio, Inc. Common Stock position peaked at $1.66M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.